How could the success of the documentary about Elizabeth Holmes affect Theranos?
The documentary's success may renew media focus on the Theranos scandal. The documentary, “You Can See Everything,” which chronicles the life of the Theranos founder, has achieved significant commercial and critical success, opening to $15 million and receiving high ratings. This high visibility and critical acclaim for the film's subject matter could drive renewed media attention and public interest toward the events and failures associated with Theranos. The film specifically follows the founder through the 34 days before she reported to prison, ensuring the company's collapse remains a prominent topic in public discourse.
- Effect
- Mild negative
- How direct
- Brind's reasoning
- When
- Within weeks
- The story
- No new developments lately
How it reaches Theranos
-
A24 announced distribution for a film starring Amanda Seyfried and production for a documentary directed by Lance Oppenheim. Separately, the A24 documentary featuring Nathan Fielder and Lance Oppenheim, which covers Elizabeth Holmes, opened to $15 million over the weekend. The film also received high critical praise, including a 99 on Metacritic and 98% on Rotten Tomatoes.
The full event1independent outlet -
The documentary, “You Can See Everything,” which details the Theranos founder's journey through the 34 days before reporting to prison, has achieved a staggering $15 million opening. This high level of public and critical visibility for the film's subject matter increases the overall media focus on the events surrounding the company's collapse.
No report states this step directly. Brind drew it from the reporting on each side of it, so treat it as an informed guess.
-
defunct American privately held health-technology company
Everything about Theranos
Tap any step to see the evidence behind it.
The facts so far
As reported. Each one links to where it comes from.
- The documentary, “You Can See Everything,” opened to a staggering $15 million over the weekend.variety.com
- The documentary is boasting a record-setting 99 on Metacritic.variety.com
- The film follows the Theranos founder through the 34 days before she reported to prison and keeps rolling afterward.variety.com
- The film is eligible for best documentary feature at the 99th Academy Awards.variety.com
Why it matters
For Theranos, which is a defunct company, the primary stake is the lasting reputational damage and the historical narrative of its failure. Renewed media attention, even if mild, keeps the scandal in the public eye, potentially influencing how the company's collapse is viewed by historians, investors, and the broader health-tech industry.
This documentary is part of a larger trend of media examining high-profile corporate failures and the promises of disruptive technology. The focus on the Theranos founder's downfall reflects a wider public interest in the ethical and operational risks inherent in rapid technological advancement.
What we don't know yet
- Will the documentary lead to new investigations into the company's former operations?
- How will the media frame the renewed interest in the Theranos scandal?
What would change this answer
Who else could feel it
Other possible ripples from the same event.
- Focus FeaturesLikelyA24's critical success may intensify competition for Focus Features
- Nathan FielderLikelyThe documentary's critical success may boost Nathan Fielder's professional standing.
- AmazonPossibleA24's critical success may increase competition for Amazon
- NetflixPossibleA24's critically acclaimed content challenges Netflix's dominance in independent film.
Reporting
- variety.comMonday
Keep going
Brind's analysis is written by AI from the reporting linked above and can be wrong. This explainer is a possibility worth considering, not a forecast: steps marked as Brind's reasoning are not stated in the reporting. It is not investment advice; do your own research.